Search Results - constantine+lyketsos

3 Results

Sort By:

Maximizing Independence at Home Dementia Care Coordination Program (MIND at Home)

Unmet NeedDementia is a leading cause of dependency and mental impairment among the elderly population, one of the most costly chronic conditions in the U.S., and ranks as the 5th leading cause of death among persons 65 and over. Over 70% of the 5.4 million Americans who suffer from dementia are cared for at home by an estimated 15 million informal...

Published: 6/27/2024 | Inventor(s): Peter Rabins, Mary Johnston, Betty Black, Constantine Lyketsos, Quincy Samus

Keywords(s): CNS and Neurological Disorders, Computing; Calculating; Counting, Data Processing Systems or Methods, Specifically Adapted fo~, Data Processing Systems or Methods, Specifically Adapted for, Dementia, Disease Indication, Neurodegeneration, Physics

Category(s): Clinical and Disease Specializations, Technology Classifications > Computers, Electronics & Software > Financial Tech, Technology Classifications > Computers, Electronics & Software, Clinical and Disease Specializations > Neurology, Clinical and Disease Specializations > Neurology > Dementia, Clinical and Disease Specializations > Neurology > Neurodegeneration

WeCareAdvisor Tool

Unmet NeedSystematic screening for behavioral symptoms in dementia is an important prevention strategy that facilitates early treatment of behavioral symptoms by identifying underlying causes and tailoring a treatment plan. If left untreated these behavioral symptoms can lead to the acceleration of the progression of the disease. First-line nonpharmacologic...

Published: 6/27/2024 | Inventor(s): Laura Gitlin, Constantine Lyketsos, Helen Kales

Keywords(s): Disease Management System, Healthcare Management, Operations Management

Category(s): Technology Classifications > Computers, Electronics & Software > Clinical Management, Technology Classifications > Computers, Electronics & Software > Healthcare IT, Technology Classifications > Computers, Electronics & Software

Oral Glucose Tolerance Test for Mild Cognitive Impairment/Alzheimer's Disease Biomarker Development

UNMET NEEDAlzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills, and eventually the ability to carry out the simplest tasks. Treatment of Alzheimer’s disease (AD) is significantly hampered by the lack of easily accessible biomarkers that can detect disease presence and predict disease risk...

Published: 6/27/2024 | Inventor(s): Esther Oh, Constantine Lyketsos, Suzanne Craft

Keywords(s): Alzheimer's Disease, Biomarker, Clinical Diagnostics, CNS and Neurological Disorders, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics, Neurodegeneration

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Geriatrics, Clinical and Disease Specializations > Neurology > Alzheimer's Disease, Clinical and Disease Specializations > Neurology > Neurodegeneration, Clinical and Disease Specializations > Rare Diseases, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > Diagnostic Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Neurology